These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32363101)

  • 1. Efficacy of Topical Finasteride 0.5% vs 17α-Estradiol 0.05% in the Treatment of Postmenopausal Female Pattern Hair Loss: A Retrospective, Single-Blind Study of 119 Patients.
    Rossi A; Magri F; D'Arino A; Pigliacelli F; Muscianese M; Leoncini P; Caro G; Federico A; Fortuna MC; Carlesimo M
    Dermatol Pract Concept; 2020; 10(2):e2020039. PubMed ID: 32363101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
    Suchonwanit P; Iamsumang W; Rojhirunsakool S
    Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Efficacy of a Combination Therapy of Topical 17α-Estradiol and Topical Minoxidil on Female Pattern Hair Loss: A Noncomparative, Retrospective Evaluation.
    Choe SJ; Lee S; Choi J; Lee WS
    Ann Dermatol; 2017 Jun; 29(3):276-282. PubMed ID: 28566902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for female pattern hair loss.
    van Zuuren EJ; Fedorowicz Z; Schoones J
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD007628. PubMed ID: 27225981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg/day in women with female pattern hair loss.
    Won YY; Lew BL; Sim WY
    Dermatol Ther; 2018 Mar; 31(2):e12588. PubMed ID: 29464847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
    Tanglertsampan C
    J Med Assoc Thai; 2012 Oct; 95(10):1312-6. PubMed ID: 23193746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo-controlled dose-effect studies with topical minoxidil 2% or 5% in male-patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol.
    Van Neste D
    Skin Res Technol; 2020 Jul; 26(4):542-557. PubMed ID: 31957152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
    Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
    Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of clinical trials using single or combination therapy of oral or topical finasteride for women in reproductive age and postmenopausal women with hormonal and nonhormonal androgenetic alopecia.
    Nobari NN; Roohaninasab M; Sadeghzadeh-Bazargan A; Goodarzi A; Behrangi E; Nikkhah F; Ghassemi M
    Adv Clin Exp Med; 2023 Jul; 32(7):813-823. PubMed ID: 36897103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: A Prospective, Single-Center, Parallel-Group, Evaluator Blinded, Randomized Trial.
    Liang X; Chang Y; Wu H; Liu Y; Zhao J; Wang L; Zhuo F
    Front Med (Lausanne); 2022; 9():905140. PubMed ID: 35899211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical finasteride for male and female pattern hair loss: Is it a safe and effective alternative?
    Gupta AK; Talukder M
    J Cosmet Dermatol; 2022 May; 21(5):1841-1848. PubMed ID: 35238144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical minoxidil fortified with finasteride: An account of maintenance of hair density after replacing oral finasteride.
    Chandrashekar BS; Nandhini T; Vasanth V; Sriram R; Navale S
    Indian Dermatol Online J; 2015; 6(1):17-20. PubMed ID: 25657911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a new combination of a microemulsion and oral supplementation for androgenetic alopecia: an interventional multicentric study.
    D'Ovidio R; Magri F; Villa L; Leoncini PP; Caro G; Muscianese M; DI Fraia M; Chieco P; Hushcha Y; Rossi A
    Ital J Dermatol Venerol; 2022 Jun; 157(3):254-261. PubMed ID: 35068112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5 mg/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss.
    Yeon JH; Jung JY; Choi JW; Kim BJ; Youn SW; Park KC; Huh CH
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):211-4. PubMed ID: 20569283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date.
    Iamsumang W; Leerunyakul K; Suchonwanit P
    Drug Des Devel Ther; 2020; 14():951-959. PubMed ID: 32184564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Efficacy and Safety of 17α-Estradiol (Ell-Cranell® alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study.
    Kim JH; Lee SY; Lee HJ; Yoon NY; Lee WS
    Ann Dermatol; 2012 Aug; 24(3):295-305. PubMed ID: 22879713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Efficacy of Topical Minoxidil Alone Against Combination of Topical Minoxidil and Platelet Rich Plasma in Women with Female Pattern Hair Loss-A Pilot, Open Randomised Trial.
    Agarwal A; Mendiratta V
    Indian J Dermatol; 2023; 68(1):121. PubMed ID: 37151237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution.
    Marotta JC; Patel G; Carvalho M; Blakeney S
    Int J Pharm Compd; 2020; 24(1):69-76. PubMed ID: 32023218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing Habits for Androgenic Alopecia Among Dermatologists in Spain in 2017: A Cross-Sectional Study.
    Pindado-Ortega C; Saceda-Corralo D; Buendía-Castaño D; Fernández-González P; Moreno-Arrones ÓM; Fonda-Pascual P; Alegre-Sánchez A; Rodrigues-Barata AR; Vañó-Galván S
    Actas Dermosifiliogr (Engl Ed); 2018; 109(6):536-542. PubMed ID: 29656764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.